These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 19729219
1. Reduced serum hepcidin levels in patients with chronic hepatitis C. Girelli D, Pasino M, Goodnough JB, Nemeth E, Guido M, Castagna A, Busti F, Campostrini N, Martinelli N, Vantini I, Corrocher R, Ganz T, Fattovich G. J Hepatol; 2009 Nov; 51(5):845-52. PubMed ID: 19729219 [Abstract] [Full Text] [Related]
2. Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion. Fujita N, Sugimoto R, Motonishi S, Tomosugi N, Tanaka H, Takeo M, Iwasa M, Kobayashi Y, Hayashi H, Kaito M, Takei Y. J Hepatol; 2008 Nov; 49(5):702-10. PubMed ID: 18620776 [Abstract] [Full Text] [Related]
3. Low hepcidin triggers hepatic iron accumulation in patients with hepatitis C. Hörl WH, Schmidt A. Nephrol Dial Transplant; 2014 Jun; 29(6):1141-4. PubMed ID: 24286977 [Abstract] [Full Text] [Related]
4. Hepcidin levels and iron status in beta-thalassemia major patients with hepatitis C virus infection. Hendy OM, Allam M, Allam A, Attia MH, El Taher S, Eldin MM, Ali A. Egypt J Immunol; 2010 Jun; 17(2):33-44. PubMed ID: 23082485 [Abstract] [Full Text] [Related]
5. Hepcidin expression in the liver: relatively low level in patients with chronic hepatitis C. Fujita N, Sugimoto R, Takeo M, Urawa N, Mifuji R, Tanaka H, Kobayashi Y, Iwasa M, Watanabe S, Adachi Y, Kaito M. Mol Med; 2007 Jun; 13(1-2):97-104. PubMed ID: 17515961 [Abstract] [Full Text] [Related]
6. Increased Duodenal Iron Absorption through Upregulation of Ferroportin 1 due to the Decrement in Serum Hepcidin in Patients with Chronic Hepatitis C. Sato M, Miyanishi K, Tanaka S, Sakurada A, Sakamoto H, Kawano Y, Takada K, Kobune M, Kato J. Can J Gastroenterol Hepatol; 2018 Jun; 2018():2154361. PubMed ID: 30186818 [Abstract] [Full Text] [Related]
7. Serum prohepcidin levels correlate with hepatic iron stores in chronic hepatitis C patients. Lin TJ, Liao LY, Chou JM, Liu SO, Wang CK. Hepatogastroenterology; 2009 Jun; 56(93):1146-51. PubMed ID: 19760959 [Abstract] [Full Text] [Related]
8. Relative contribution of iron genes, dysmetabolism and hepatitis C virus (HCV) in the pathogenesis of altered iron regulation in HCV chronic hepatitis. Valenti L, Pulixi EA, Arosio P, Cremonesi L, Biasiotto G, Dongiovanni P, Maggioni M, Fargion S, Fracanzani AL. Haematologica; 2007 Aug; 92(8):1037-42. PubMed ID: 17640859 [Abstract] [Full Text] [Related]
9. Changes in the Serum Hepcidin-to-ferritin Ratio with Erythroferrone after Hepatitis C Virus Eradication Using Direct-acting Antiviral Agents. Inomata S, Anan A, Yamauchi E, Yamauchi R, Kunimoto H, Takata K, Tanaka T, Yokoyama K, Morihara D, Takeyama Y, Irie M, Shakado S, Sohda T, Sakisaka S. Intern Med; 2019 Oct 15; 58(20):2915-2922. PubMed ID: 31243222 [Abstract] [Full Text] [Related]
10. Increased serum hepcidin levels in patients with porphyria cutanea tarda. Darwich E, To-Figueras J, Molina-López RA, Deulofeu R, Olbina G, Westerman M, Sánchez-Tápias JM, Muñoz-Santos C, Herrero C. J Eur Acad Dermatol Venereol; 2013 Jan 15; 27(1):e68-74. PubMed ID: 22429447 [Abstract] [Full Text] [Related]
11. Iron overload and glucose abnormalities in chronic hepatitis C virus infection: phlebotomy lowers risk of new-onset diabetes. Mifuji-Moroka R, Iwasa M, Miyachi H, Sugimoto R, Tanaka H, Ishihara T, Fujita N, Kaito M, Kobayashi Y, Takei Y. Hepatogastroenterology; 2013 Oct 15; 60(127):1736-41. PubMed ID: 24634944 [Abstract] [Full Text] [Related]
12. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C. Tsochatzis E, Papatheodoridis GV, Koliaraki V, Hadziyannis E, Kafiri G, Manesis EK, Mamalaki A, Archimandritis AJ. J Viral Hepat; 2010 Nov 15; 17(11):800-6. PubMed ID: 20002304 [Abstract] [Full Text] [Related]
13. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Origa R, Galanello R, Ganz T, Giagu N, Maccioni L, Faa G, Nemeth E. Haematologica; 2007 May 15; 92(5):583-8. PubMed ID: 17488680 [Abstract] [Full Text] [Related]
14. Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome. Luque-Ramírez M, Álvarez-Blasco F, Alpañés M, Escobar-Morreale HF. J Clin Endocrinol Metab; 2011 Mar 15; 96(3):846-52. PubMed ID: 21209031 [Abstract] [Full Text] [Related]
15. Is iron overload in alcohol-related cirrhosis mediated by hepcidin? Iqbal T, Diab A, Ward DG, Brookes MJ, Tselepis C, Murray J, Elias E. World J Gastroenterol; 2009 Dec 14; 15(46):5864-6. PubMed ID: 19998511 [Abstract] [Full Text] [Related]
16. Liver hepcidin mRNA expression is inappropriately low in alcoholic patients compared with healthy controls. Costa-Matos L, Batista P, Monteiro N, Simões M, Egas C, Pereira J, Pinho H, Santos N, Ribeiro J, Cipriano MA, Henriques P, Girão F, Rodrigues A, Carvalho A. Eur J Gastroenterol Hepatol; 2012 Oct 14; 24(10):1158-65. PubMed ID: 22732356 [Abstract] [Full Text] [Related]
17. Relationship of serum haemojuvelin and hepcidin levels with iron level and erythropoietin requirement in prevalent hepatitis C virus positive haemodialysis patients. El Said HW, Abou Seif KH, Ahmed YS, Abou Elleil HA, El Said TW, Behairy MA, Mohamed MM, Ahmed FA. Nephrology (Carlton); 2018 Apr 14; 23(4):323-330. PubMed ID: 28130911 [Abstract] [Full Text] [Related]
18. The Relationship of Serum Hemojuvelin and Hepcidin Levels with Iron Overload in Nonalcoholic Fatty Liver Disease. Boga S, Alkim H, Alkim C, Koksal AR, Bayram M, Yilmaz Ozguven MB, Tekin Neijmann S. J Gastrointestin Liver Dis; 2015 Sep 14; 24(3):293-300. PubMed ID: 26405701 [Abstract] [Full Text] [Related]
19. Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency. Foka P, Dimitriadis A, Karamichali E, Kyratzopoulou E, Giannimaras D, Koskinas J, Varaklioti A, Mamalaki A, Georgopoulou U. Virulence; 2016 Aug 17; 7(6):679-90. PubMed ID: 27058404 [Abstract] [Full Text] [Related]
20. Hepcidin--a potential novel biomarker for iron status in chronic kidney disease. Zaritsky J, Young B, Wang HJ, Westerman M, Olbina G, Nemeth E, Ganz T, Rivera S, Nissenson AR, Salusky IB. Clin J Am Soc Nephrol; 2009 Jun 17; 4(6):1051-6. PubMed ID: 19406957 [Abstract] [Full Text] [Related] Page: [Next] [New Search]